74 related articles for article (PubMed ID: 20003812)
1. Risk factors of invasive cervical cancer in Morocco.
Meftah el khair M; Ait Mhand R; Mzibri ME; Ennaji MM
Cell Mol Biol (Noisy-le-grand); 2009 Nov; 55 Suppl():OL1175-85. PubMed ID: 20003812
[TBL] [Abstract][Full Text] [Related]
2. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
Castellsagué X; Muñoz N
J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
[TBL] [Abstract][Full Text] [Related]
4. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
6. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
7. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women.
Tornesello ML; Buonaguro L; Izzo S; Lopez G; Vega X; Maldonado Reyes CF; Buonaguro FM
J Med Virol; 2008 Nov; 80(11):1959-65. PubMed ID: 18814248
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy.
Broccolo F; Chiari S; Piana A; Castiglia P; Dell'Anna T; Garcia-Parra R; Maneo A; Villa A; Leone EB; Perego P; Maida A; Mangioni C; Cocuzza CE
J Med Virol; 2009 Feb; 81(2):278-87. PubMed ID: 19107971
[TBL] [Abstract][Full Text] [Related]
12. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus detection in Moroccan patients with bladder cancer.
Berrada N; Al-Bouzidi A; Ameur A; Abbar M; El-Mzibri M; Ameziane-El-Hassani R; Benbacer L; Khyatti M; Qmichou Z; Amzazi S; Attaleb M
J Infect Dev Ctries; 2013 Aug; 7(8):586-92. PubMed ID: 23949293
[TBL] [Abstract][Full Text] [Related]
15. Environmental co-factors in HPV carcinogenesis.
Castellsagué X; Bosch FX; Muñoz N
Virus Res; 2002 Nov; 89(2):191-9. PubMed ID: 12445659
[TBL] [Abstract][Full Text] [Related]
16. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study.
Berraho M; Amarti-Riffi A; El-Mzibri M; Bezad R; Benjaafar N; Benideer A; Matar N; Qmichou Z; Abda N; Attaleb M; Znati K; El Fatemi H; Bendahhou K; Obtel M; Filali Adib A; Mathoulin-Pelissier S; Nejjari C
BMC Cancer; 2017 Jun; 17(1):435. PubMed ID: 28633667
[TBL] [Abstract][Full Text] [Related]
17. [Tobacco smoking and HPV infection].
Maciejewska J; Walentowicz M; Bodnar M; Grabiec M; Marszałek A
Przegl Lek; 2010; 67(10):847-9. PubMed ID: 21360912
[TBL] [Abstract][Full Text] [Related]
18. The role of human papilloma virus (HPV) in the aetiology of cervical cancer.
Malik AI
J Pak Med Assoc; 2005 Dec; 55(12):553-8. PubMed ID: 16438278
[No Abstract] [Full Text] [Related]
19. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer.
Faridi R; Zahra A; Khan K; Idrees M
Virol J; 2011 Jun; 8():269. PubMed ID: 21635792
[TBL] [Abstract][Full Text] [Related]
20. [Escape mechanisms to the innate immune response in HPV-associated cervical cancer].
del Toro-Arreola S; García-Chagollán M; Jave-Suárez LF
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S194-9. PubMed ID: 26462516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]